New drug Aviptadil provides rapid recovery for critical Covid-19 patients
Shortpedia
Content Team
Image Credit: shortpedia
Amid rising number of coronavirus cases, doctors at a hospital in Houston have used a new drug called RLF-100, also known as aviptadil, that has led to rapid recovery from respiratory failure in critically ill Covid patients. The drug has been approved by FDA for emergency use at multiple clinical sites in patients who are too ill to enter the FDA's Phase 2/3 trials. Houston Methodist Hospital was the first to report the rapid recovery.
